Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
| 18 | 3 | HEMATOLOGY//THROMBOSIS AND HAEMOSTASIS//THROMBOSIS RESEARCH | 124610 |
| 518 | 2 | ASPIRIN RESISTANCE//ASPIRIN//THROMBOSIS RESEARCH | 15555 |
| 33588 | 1 | INDOBUFEN//INDOBUFEN ENANTIOMERS//2 2 3 4 5 TRIMETHOXYBENZOYLOXYETHYLPYRROLIDINE HYDROCHLORIDE | 136 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | INDOBUFEN | authKW | 1335269 | 8% | 52% | 11 |
| 2 | INDOBUFEN ENANTIOMERS | authKW | 463485 | 1% | 100% | 2 |
| 3 | 2 2 3 4 5 TRIMETHOXYBENZOYLOXYETHYLPYRROLIDINE HYDROCHLORIDE | authKW | 231743 | 1% | 100% | 1 |
| 4 | 6 KETO PGF 1 ALPHA | authKW | 231743 | 1% | 100% | 1 |
| 5 | 90 OMEGA 3 POLYUNSATURATED FATTY ACID PFA | authKW | 231743 | 1% | 100% | 1 |
| 6 | ANTITHROMBOTIC COMPOUND | authKW | 231743 | 1% | 100% | 1 |
| 7 | ASA HYPERSENSITIVITY | authKW | 231743 | 1% | 100% | 1 |
| 8 | BIOGENIC CHLORAMINE | authKW | 231743 | 1% | 100% | 1 |
| 9 | BLOOD RHEOLOGICAL PARAMETERS | authKW | 231743 | 1% | 100% | 1 |
| 10 | CARLO ERBA ERBAMONT GRP CARDIOVASC S | address | 231743 | 1% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 664 | 41% | 0% | 56 |
| 2 | Peripheral Vascular Diseases | 320 | 15% | 0% | 20 |
| 3 | Hematology | 295 | 15% | 0% | 20 |
| 4 | Medicine, Research & Experimental | 274 | 18% | 0% | 24 |
| 5 | Chemistry, Multidisciplinary | 120 | 21% | 0% | 29 |
| 6 | Chemistry, Medicinal | 30 | 5% | 0% | 7 |
| 7 | Cardiac & Cardiovascular System | 19 | 6% | 0% | 8 |
| 8 | Medicine, General & Internal | 7 | 5% | 0% | 7 |
| 9 | Chemistry, Analytical | 6 | 4% | 0% | 6 |
| 10 | Integrative & Complementary Medicine | 3 | 1% | 0% | 1 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CARLO ERBA ERBAMONT GRP CARDIOVASC S | 231743 | 1% | 100% | 1 |
| 2 | HOLON INTEGRAT CANC | 231743 | 1% | 100% | 1 |
| 3 | PHYSIOL HAEMOSTASIS | 231743 | 1% | 100% | 1 |
| 4 | PHYSISOCHEM MED | 231743 | 1% | 100% | 1 |
| 5 | CHAIR ANGIOL BLOOD COAGULAT | 115870 | 1% | 50% | 1 |
| 6 | PROGRAM CLIN NUTR | 57934 | 1% | 25% | 1 |
| 7 | HLTH SCI INTERNAL MED CARDIOVASC | 46347 | 1% | 20% | 1 |
| 8 | HEART GREAT VESSELS ATTILIO REALE | 3217 | 1% | 1% | 1 |
| 9 | PHYS PHARM PHARMACOKINET | 2969 | 1% | 1% | 1 |
| 10 | ANGIOL BLOOD COAGULAT | 2895 | 1% | 1% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY | 107771 | 14% | 2% | 19 |
| 2 | PHARMATHERAPEUTICA | 6594 | 2% | 1% | 3 |
| 3 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 5853 | 8% | 0% | 11 |
| 4 | JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | 2135 | 4% | 0% | 6 |
| 5 | ACTA PHARMACOLOGICA SINICA | 1982 | 5% | 0% | 7 |
| 6 | THROMBOSIS RESEARCH | 1426 | 6% | 0% | 8 |
| 7 | PHARMACOLOGICAL RESEARCH COMMUNICATIONS | 1012 | 1% | 0% | 2 |
| 8 | COR ET VASA | 682 | 1% | 0% | 1 |
| 9 | CHIRALITY | 670 | 2% | 0% | 3 |
| 10 | PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS | 640 | 1% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |